e.g. Tata motors, Reliance MF, 500570

Alivus Life Sciences Ltd. - Research Center

543322 ALIVUS Group (A) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 26 Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22
Income
Operating income 2,551.83 2,386.88 2,283.21 2,161.22 2,123.21
Expenses
Material consumed 1,085.92 1,096.70 1,017.53 1,028.87 1,055.04
Manufacturing expenses 119.92 119.67 115.63 118.08 103.57
Personnel expenses 272.47 251.70 258.16 180.18 168.72
Selling expenses - - - - -
Adminstrative expenses 276.24 236.24 217.65 191.80 179.82
Expenses capitalised - - - - -
Cost of sales 1,754.55 1,704.30 1,608.97 1,518.93 1,507.15
Operating profit 797.28 682.58 674.25 642.29 616.06
Other recurring income 60.41 34.57 12.04 28.96 14.70
Adjusted PBDIT 857.70 717.15 686.29 671.25 630.76
Financial expenses 5.37 2.41 1.55 0.55 27.96
Depreciation 75.36 60.61 53.45 42.09 37.88
Other write offs - - - - -
Adjusted PBT 776.97 654.13 631.29 628.61 564.93
Tax charges 186.83 168.50 160.40 161.65 146.20
Adjusted PAT 590.14 485.63 470.89 466.96 418.72
Non recurring items -24.43 -1.25 -5.46 -0.29 0.10
Other non cash adjustments - - - - -
Reported net profit 565.71 484.38 465.43 466.67 418.82
Earnigs before appropriation 2,342.89 1,776.18 1,567.49 1,488.02 1,169.61
Equity dividend 61.34 - 275.69 385.96 128.65
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 2,281.55 1,776.18 1,291.80 1,102.06 1,040.95
Close
Add Alivus Life Sciences Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Alivus Life Sciences Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback